Birdwatch Note Rating
2024-05-07 05:07:37 UTC - HELPFUL
Rated by Participant: C7F20C0C9CA70BA453E265D47470EEE17FA6790B2260602B066ABCB4063CCC7F
Participant Details
Original Note:
The revocation was made at the request of AstraZeneca itself: ".... withdrawing, at the holder's request, the marketing authorisation granted by Decision C(2021) 698(final) for "Vaxzevria - COVID-19 Vaccine (ChAdOx1-S [recombinant])", a medicinal product for human use" https://ec.europa.eu/health/documents/community-register/2024/20240327162288/dec_162288_en.pdf
All Note Details